Alternatives to MedLeanRx

Async-first compounded GLP-1 with a rarity for this list — free health coaching — at a flat one-price-all-doses rate. Fast and friendly up front; the strict, non-refundable fine print is the trade-off.

The async, needle-optional value play: oral or injectable semaglutide and tirzepatide from a low starting price, no video visit, ~3 days to a script — listed with its February 2026 FDA warning letter in plain view.

Compounded semaglutide from $149 a month and tirzepatide from $199, with a genuine microdose line at $129 and a dissolving oral tablet at $169 — a wider catalog than most, and it includes hormone therapy for women from $69. The number to ignore is the one it leads with. 'Starting at $99/mo' runs across every page, and no GLP-1 on the site costs $99: the cheapest is the $129 microdose. The $99 belongs to its NAD+ nasal spray. Two more gaps worth knowing. Every price is a floor, with no ongoing rate published. And it names no company anywhere — no LLC, no address, nothing in the terms or privacy policy.

FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, and licensed in all 50 states. It also cites customer-reported outcomes (125k patients, 1M+ pounds lost) rather than leaving weight-loss claims unsourced.

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.

A granular GLP-1 menu — microdose from $129/mo, semaglutide from $149/mo, tirzepatide from $249/mo, plus an exclusive combined 'GLP-Squared' injection — all stated as all-inclusive, though the site doesn't itemize exactly what that covers.

If injections are the blocker, this is the one to look at: DoctorAdam sells GLP-1s only as daily oral tablets, with no injectable in the catalog at all. Semaglutide tablets from $129 a month, tirzepatide tablets from $199, all fifty states, flat monthly pricing with no hidden fees. It also names its clinicians and publishes an Anaheim address. One caution when reading the grid: NAD+ injections carry the same $129 and sit near the semaglutide card.

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear.

There is no way to price Believe without applying to it. Its three GLP-1 treatment pages were read end to end and carry no dollar figure at all; the only number on the homepage is a badge promising nothing is charged if you are not approved. Behind the eligibility gate the menu is four plans, each flat at every dose: semaglutide $149 a month against a struck-through $249, tirzepatide $229 against $299 and marked most chosen, a microdose at $199, and a daily oral at $229. Those are competitive figures with two complications. The microdose costs $50 a month more than standard semaglutide, the reverse of what a lower dose implies. And two of the four plans never name a molecule, so you would be choosing between products without being told which drug is in them. It claims fifty-state care without listing states, names no pharmacy, and publishes no time to first dose.